• 4828 Citations
  • 36 h-Index
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Wei Hu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 4828 Citations
  • 36 h-Index
  • 93 Article
  • 19 Review article
  • 2 Comment/debate
  • 1 Chapter

Clinical and biological significance of EZH2 expression in endometrial cancer

Roh, J. W., Choi, J. E., Han, H. D., Hu, W., Matsuo, K., Nishimura, M., Lee, J. S., Kwon, S. Y., Cho, C. H., Kim, J., Coleman, R. L., Lopez-Bernstein, G. & Sood, A. K., Feb 1 2020, In : Cancer Biology and Therapy. 21, 2, p. 147-156 10 p.

Research output: Contribution to journalArticle

  • 5 Scopus citations

    Pan-cancer clinical and molecular analysis of racial disparities

    Lara, O. D., Wang, Y., Asare, A., Xu, T., Chiu, H. S., Liu, Y., Hu, W., Sumazin, P., Uppal, S., Zhang, L., Rauh-Hain, J. A. & Sood, A. K., Feb 15 2020, In : Cancer. 126, 4, p. 800-807 8 p.

    Research output: Contribution to journalArticle

  • Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells

    Li, Y., Yang, S., Sadaoui, N. C., Hu, W., Dasari, S. K., Mangala, L. S., Sun, Y., Zhao, S., Wang, L., Liu, Y., Ramondetta, L. M., Li, K., Lu, C., Kang, Y., Cole, S. W., Lutgendorf, S. K. & Sood, A. K., Jul 24 2020, In : iScience. 23, 7, 101289.

    Research output: Contribution to journalArticle

    Open Access
  • Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer

    Lara, O. D., Bayraktar, E., Amero, P., Ma, S., Ivan, C., Hu, W., Wang, Y., Mangala, L. S., Dutta, P., Bhattacharya, P. K., Ashizawa, A. T., Lopez-Berestein, G., Rodriguez-Aguayo, C. & Sood, A. K., Jul 21 2020, In : Oncotarget. 11, 29, p. 2819-2833 15 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    GnRH-R-Targeted lytic peptide sensitizes BRCA wild-type ovarian cancer to PARP inhibition

    Ma, S., Pradeep, S., Villar-Prados, A., Wen, Y., Bayraktar, E., Mangala, L. S., Kim, M. S., Wu, S. Y., Hu, W., Rodriguez-Aguayo, C., Leuschner, C., Liang, X., Ram, P. T., Schlacher, K., Coleman, R. L. & Sood, A. K., 2019, In : Molecular cancer therapeutics. 18, 5, p. 969-979 11 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations